THEPRP News

Megadeth

Megadeth Play First Show Since Dave Mustaine’s Cancer Diagnosis, Footage Available


0

Megadeth hit the stage today, January 20th, for their first live show since their vocalist/guitarist Dave Mustaine underwent treatment for cancer last year. Mustaine spent much of 2019 focused on his health after revealing this past June that he had been diagnosed with a squamous cell carcinoma on base of his tongue. He subsequently underwent radiation treatment for it and began the rehabilitation process this past fall.

For their first show back, the band played the Hartwall Areena in Helsinki, Finland as part of Megadeth‘s ongoing tour with Five Finger Death Punch and Bad Wolves. The setlist, according to those in attendance today, ran as follows:

- Advertisement -

Hangar 18
Wake Up Dead
Sweating Bullets
Dawn Patrol
Trust
A Tout le Monde
She-Wolf
Dystopia
Symphony Of Destruction
Peace Sells
Holy Wars… The Punishment Due

Fan-filmed footage is available below. The remaining dates for Megadeth‘s run as direct support to Five Finger Death Punch on the aforementioned tour include:

01/20 Helsinki, FIN – Hartwell Arena (Tickets)
01/22 Stockholm, SWE – Hovet
01/23 Oslo, NOR – Spektrum
01/24 Copenhagen, DEN – Royal Arena (Tickets)
01/26 Amsterdam, NET – AFAS Live (Tickets)
01/28 Paris, FRA – Zenith (Tickets)
01/30 Cardiff, UK – Cardiff Arena (Tickets)
01/31 London, UK – Wembley Arena (Tickets)
02/03 Berlin, GER – Max-Schmeling Halle (Tickets)
02/04 Hamburg, GER – Sporthalle (Tickets)
02/06 Frankfurt, GER – Festhalle (Tickets)
02/08 Oberhausen, GER – Koenig-Pilsener Arena (Tickets)
02/09 Stuttgart, GER – Schleyerhalle (Tickets)
02/10 Munich, GER – Olympiahalle (Tickets)
02/12 Warsaw, POL – Torwar
02/14 Prague, CZE – Tipsport Arena (Tickets)
02/16 Milan, ITA – Alcatrazz (Tickets)
02/17 Zurich, SWI – Hallenstadion (Tickets)
02/19 Vienna, AUT – Stadthalle (Tickets)
02/20 Budapest, HUN – Budapest Sportarena (Tickets)

Theprp.com may receive a commission from tickets purchased through the links in the above post.

Comments